The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.

about

The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.

Item

http://www.wikidata.org/entity/Q41948740

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The impact of adjuvant therapy ...... s after radical prostatectomy.

@en

type

Item

label

The impact of adjuvant therapy ...... s after radical prostatectomy.

@en

prefLabel

The impact of adjuvant therapy ...... s after radical prostatectomy.

@en

P1476

The impact of adjuvant therapy ...... s after radical prostatectomy.

@en

P2093

Andrzej Paradysz

http://www.w3.org/2001/XMLSchema#string

Maciej Szczębara

http://www.w3.org/2001/XMLSchema#string

Marian Suchodolski

http://www.w3.org/2001/XMLSchema#string

Mieczysław Fryczkowski

http://www.w3.org/2001/XMLSchema#string

Piotr Bryniarski

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects.

Natural history of progression after PSA elevation following radical prostatectomy.

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

Prostate specific antigen only progression of prostate cancer.

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.

PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer.

Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.

P304

218-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5173/CEJU.2011.04.ART6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260432120

http://www.w3.org/2001/XMLSchema#string

P698

24578897

http://www.w3.org/2001/XMLSchema#string

P932

3921737

http://www.w3.org/2001/XMLSchema#string